References
- Andersen JK. Oxidative stress in neurodegeneration: cause or consequence? Nat Med 2004; 10 ( Suppl): S18-S25.
- Fleury C, Mignotte B, Vayssière JL. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 2002; 84: 131–141.
- Soleas GJ, Diamandis EP, Goldberg DM. Resveratrol: a molecule whose time has come? And gone? CIM Biochem 1997; 30: 91–113.
- Bradamante S, Barenghi L, Piccinini F et al. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism. Eur J Pharmacol 2003; 465: 115–123.
- Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J Biol Chem 2005; 280: 37377–37382.
- Sebai H, Ben-Attia M, Sani M, Aouani E, Ghanem-Boughanmi N. Protective effect of resveratrol on acute endotoxemia-induced nephrotoxicity in rat through nitric oxide independent mechanism. Free Radic Res 2008; 42: 913–920.
- Kasdallah-Grissa A, Momagui B, Aouani E et al. Resveratrol, a red wine polyphenol, attenuates ethanol-induced oxidative stress in rat liver. Life Sci 2007; 80: 1033–1039.
- Mokni M, Elkahoui S, Limam F, Amri M, Aouani E. Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem Res 2007; 32: 981–987.
- Mokni M, Limam F, Elkahoui S, Amri M, Aouani E. Strong cardioprotective effect of resveratrol, a red wine polyphenol, on isolated rat hearts after ischemia/reperfusion injury. Arch Biochem Biophys 2007; 457: 1–6.
- Sani M, Ghanem-Boughanmi N, Gadacha W et al. Malondialdehyde content and circadian variations in brain, kidney, liver and plasma of mice. Chronobiol Int 2007; 24: 671–685.
- Cardona E Periodic dip of lipid peroxidation in humans: a redox signal to synchronize peripheral circadian clocks? Med Hypotheses 2004; 63: 841–846.
- Portaluppi F, Touitou Y, Smolensky MH. Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol Int 2008; 25: 999–1016.
- Yagi K. A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 1976; 15: 212–216.
- Brown RE, Jarvis KL, Hyland KJ. Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem 1989; 180: 136–139.
- Juan ME, Vinardell MP, Planas JM. The daily oral administration of high doses of trans-resveratrol to rats for 28 days is not harmful. J Nutr 2002; 132: 257–260.
- Farooqui MY, Ahmed AE. Circadian periodicity of tissue glutathione and its relationship with lipid peroxidation in rats. Life Sci 1984; 34: 2413–2418.
- Solar P, Toth G, Smajda B, Ahlers I, Ahlersova E. Circadian and circaannual oscillations of tissue lipoperoxides in rats. Physiol Res 1995; 44: 249–256.
- Morera AL, Abreu P. Day-time/night-time and summer/winter melatonin and malondialdehyde rhythms: an inverse relationship. J Pineal Res 2007; 43: 313–314.
- Yano M, Hasegawa G, Ishii M et al. Short-term exposure of high glucose concentration induces generation of reactive oxygen species in endothelial cells: implication for the oxidative stress associated with postprandial hyperglycemia. Redox Rep 2004; 9: 111–116.
- Pownall HJ. Alcohol: lipid metabolism and cardioprotection. Curr Atheroscler Rep 2002; 4: 107–112.
- Osseni RA, Rat P, Bogdan A, Wamet JM, Touitou Y. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 2000; 68: 387–399.
- Robaszkiéwicz A, Balcerczyk A, Bartosz G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol Int 2007; 31: 1245–1250.
- Tian B, Sun Z, Xu Z, Hua Y. Chemiluminescence analysis of the prooxidant and antioxidant effects of epigallocatechin 3-gallate. Asia Pac J Clin Nutr 2007; 16: 153–157.
- Delalastra CA, Villegas I. Resveratrol as an antioxidant and prooxidant agent: mechanisms and clinical implication. Biochem Soc Trans 2007; 35: 1156–1160.
- Das S, Das DK. Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Patents Cardiovasc Drug Discov 2007; 2: 133–138.